Literature DB >> 12498984

A low molecular weight antioxidant decreases weight and lowers tumor incidence.

James B Mitchell1, Sandhya Xavier, Anne M DeLuca, Anastasia L Sowers, John A Cook, Murali C Krishna, Stephen M Hahn, Angelo Russo.   

Abstract

Stable free radical nitroxides are potent antioxidants possessing superoxide dismutase- and catalase-mimetic activity that protect cells and animals against a variety of oxidative insults. Tempol, as a representative nitroxide, was evaluated for its influence on weight maintenance and spontaneous tumor incidence in C3H mice. Tempol administered in either the drinking water or food did not show any untoward effects and prevented animals from becoming obese. Tempol-treated animals' leptin levels were reduced. Long-term treatment with Tempol significantly decreased tumorigenesis when compared to controls (10 vs. 40%, respectively). Selected tissues from Tempol-treated animals exhibited elevated levels of mitochrondrial uncoupling protein-2 (UCP-2) and HSP70. The present data suggest that nitroxides upregulate UCP-2, obviate weight gain, and decrease age-related spontaneous tumor incidence. As a class, nitroxides may provide overall health benefits by contributing to decreased obesity and tumor incidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498984     DOI: 10.1016/s0891-5849(02)01193-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  42 in total

Review 1.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 2.  Uncouple my heart: the benefits of inefficiency.

Authors:  Martin Modrianský; Eva Gabrielová
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 3.  An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.

Authors:  Frank J Gonzalez; Changtao Jiang; Andrew D Patterson
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

Review 4.  From spin-labeled proteins to in vivo EPR applications.

Authors:  Lawrence J Berliner
Journal:  Eur Biophys J       Date:  2009-09-11       Impact factor: 1.733

5.  Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.

Authors:  Courtney G Havens; Alan Ho; Naohisa Yoshioka; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.

Authors:  James B Mitchell; Miriam R Anver; Anastasia L Sowers; Philip S Rosenberg; Maria Figueroa; Angela Thetford; Murali C Krishna; Paul S Albert; John A Cook
Journal:  Cancer Res       Date:  2012-07-17       Impact factor: 12.701

7.  Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.

Authors:  Alexandros G Georgakilas; Christophe E Redon; Nicholas F Ferguson; Thomas B Kryston; Palak Parekh; Jennifer S Dickey; Asako J Nakamura; James B Mitchell; William M Bonner; Olga A Martin
Journal:  Cancer Lett       Date:  2014-07-25       Impact factor: 8.679

Review 8.  Bile acids as metabolic regulators.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Curr Opin Gastroenterol       Date:  2015-03       Impact factor: 3.287

9.  Antioxidant properties of MitoTEMPOL and its hydroxylamine.

Authors:  Jan Trnka; Frances H Blaikie; Angela Logan; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Res       Date:  2009-01

Review 10.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.